Abstract:Micelle drugs based on a polymeric platform offer great advantages over liposomal drugs for tumor treatment. Although nearly all of the nanomedicines approved in the clinical use can passively target to the tumor tissues on the basis of an enhanced permeability and retention (EPR) effect, the nanodrugs have shown heterogenous responses in the patients. This phenomenon may be traced back to the EPR effect of tumor, which is extremely variable in the individuals from extensive studies. Nevertheless, there is a lack of experimental data describing the EPR effect and predicting its impact on therapeutic efficacy of nanoagents. Herein, we developed 32 nm magnetic iron oxide nanoparticles (MION) as a T2-weighted contrast agent to describe the EPR effect of each tumor by in vivo magnetic resonance imaging (MRI). The MION were synthesized by a thermal decomposition method and modified with DSPE-PEG2000 for biological applications. The PEGylated MION (Fe3O4@PEG) exhibited high r2 of 571 mM-1 s-1 and saturation magnetization (Ms) of 94 emu g-1 Fe as well as long stability and favorable biocompatibility through the in vitro studies. The enhancement intensities of the tumor tissue from the MR images were quantitatively measured as TNR (Tumor/Normal tissue signal Ratio) values, which were correlated with the delay of tumor growth after intravenous administration of the PLA-PEG/PTX micelle drug. The results demonstrated that the group with the smallest TNR values (TNR < 0.5) displayed the best tumor inhibitory effect. In addition, there was a superior correlation between TNR value and relative tumor delay in individual mice. These analysis results indicated that the TNR value of the tumor region enhanced by Fe3O4@PEG (d = 32 nm) could be used to predict the therapeutic efficacy of the micelle drugs (d ≤ 32 nm) in a certain period of time. Fe3O4@PEG has a potential to serve as an ideal MRI contrast agent to visualize the EPR effect in patients for accurate medication guidance of micelle drugs in the future treatment of tumors.

Magnetic Nanoparticles for Magnetic Resonance Imaging: Modulation of Macrophage Uptake by Controlled PEGylation of the Surface Coating

PEG- b -AGE Polymer Coated Magnetic Nanoparticle Probes with Facile Functionalization and Anti-fouling Properties for Reducing Non-specific Uptake and Improving Biomarker Targeting.

Characterization and in Vitro Cellular Uptake of PEG Coated Iron Oxide Nanoparticles As MRI Contrast Agent.

Fabrication of Uniform, Biocompatible and Multifunctional PCL-b-PAA Copolymer-Based Hybrid Micelles for Magnetic Resonance Imaging

Investigation of magnetic resonance contrast properties of PEG-Coated gadolinium oxide nanoparticles in various biological environments

Polyethylene Glycol Modified, Cross-Linked Starch-Coated Iron Oxide Nanoparticles for Enhanced Magnetic Tumor Targeting

Magnetic Brain Tumor Targeting and Biodistribution of Long-Circulating PEG-modified, Cross-Linked Starch-Coated Iron Oxide Nanoparticles

Effective PEGylation of Fe<SUB>3</SUB>O<SUB>4</SUB> Nanomicelles for <i>in Vivo</I> MR Imaging

A Functional Iron Oxide Nanoparticles Modified with PLA-PEG-DG As Tumor-Targeted MRI Contrast Agent

Engineered magnetic hybrid nanoparticles with enhanced relaxivity for tumor imaging

Solvent-free Atom Transfer Radical Polymerization for the Preparation of Poly(poly(ethyleneglycol) Monomethacrylate)-Grafted Fe3O4 Nanoparticles: Synthesis, Characterization and Cellular Uptake.

Stimuli-Responsive Biodegradable Hyperbranched Polymer–Gadolinium Conjugates as Efficient and Biocompatible Nanoscale Magnetic Resonance Imaging Contrast Agents

Controlled PEGylation of Monodisperse Fe3O4 Nanoparticles for Reduced Non-Specific Uptake by Macrophage Cells

Ultrasmall catechol-PEG-anchored ferrite nanoparticles for high-sensitive magnetic resonance angiography

Fluorescent-Magnetic Poly(Poly(Ethyleneglycol)Monomethacrylate)-Grafted Fe3o4 Nanoparticles From Post-Atom-Transfer-Radical-Polymerization Modification: Synthesis, Characterization, Cellular Uptake And Imaging

Using PEGylated Magnetic Nanoparticles to Describe the EPR Effect in Tumor for Predicting Therapeutic Efficacy of Micelle Drugs

Fe3O4 Nanoparticles Functionalized with Polymer Ligand for T-1-Weighted MRI in Vitro and in Vivo

Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent.

Polydopamine Coated Manganese Oxide Nanoparticles with Ultrahigh Relaxivity As Nanotheranostic Agents for Magnetic Resonance Imaging Guided Synergetic Chemo-/Photothermal Therapy.

Metallic Iron Nanoparticles for MRI Contrast Enhancement and Local Hyperthermia.

Surface Modification of Magnetites Using Maltotrionic Acid and Folic Acid for Molecular Imaging